| Basics |
|
Unity Biotechnology, Inc.
|
| IPO Date: |
April 30, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.13M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 3.69%
|
| Avg Daily Range (30 D): |
$0.02 | 7.68%
|
| Avg Daily Range (90 D): |
$0.04 | 4.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.47M |
| Avg Daily Volume (30 D): |
.61M |
| Avg Daily Volume (90 D): |
.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
195 |
| Avg Trade Size (Sh.) (30 D): |
545 |
| Avg Trade Size (Sh.) (90 D): |
401 |
| Institutional Trades |
| Total Inst.Trades: |
85 |
| Avg Inst. Trade: |
$1.92M |
| Avg Inst. Trade (30 D): |
$.79M |
| Avg Inst. Trade (90 D): |
$.79M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.26M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
44.4K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-1.62
|
$-.43
|
$-.5
|
|
Diluted EPS
|
$-1.62
|
$-.43
|
$-.5
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -27.5M
|
$ -7.3M
|
$ -8.44M
|
|
Operating Income / Loss
|
$ -30.46M
|
$ -6.89M
|
$ -9.99M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -12.22M
|
$ M
|
$ -1.32M
|
|
PE Ratio
|
|
|
|
|
|
|